BAX vs SOLV
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BAX · Baxter International Inc$25.39 ▲ 0.00%
SOLV · Solventum$84.50 ▼ 1.52%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BAX +39.9%
- SOLV +1.3%
Head to head
| Metric | BAX | SOLV |
|---|---|---|
| Price | $25.39 | $84.50 |
| Change today | ▲ 0.00% | ▼ 1.52% |
| Market cap | $13.14B | $14.34B |
| Return, 3 months | -4.1% | -7.4% |
| Return, year to date | +33.0% | +6.6% |
| Return, 1 year | +38.9% | +1.9% |
| P/E (TTM) | – | 94.9 |
| P/B | 2.0 | 3.0 |
| P/E percentile vs own 5y | 21st | 99th |
| Dividend yield | 0.16% | – |
| Revenue growth (YoY, latest qtr) | +5.0% | -7.0% |
| Net profit growth (YoY) | +739.1% | -100.9% |
| Gross margin | 30.1% | 54.8% |
| Operating margin | 2.3% | 5.2% |
| Net margin | -6.2% | 1.9% |
| Return on equity | -10.5% | 3.2% |
| Analyst target vs. price | -1.5% | +20.9% |
| Analyst buy share | 0% | 63% |
| RSI (14) | 50 | 42 |
| 30-day volatility | 43.9% | 33.2% |
| Max drawdown, 1 year | -29.0% | -27.5% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SOLV is the largest of the group by market value.
- BAX has returned the most over the past year.
- BAX is growing revenue fastest.
- SOLV keeps the most profit per dollar of sales.
- SOLV has been the calmest stock over the last 30 days.